Evidence map›Paper›PMID 17603109›Full record

ArticleGenetics2007

Golgi manganese transport is required for rapamycin signaling in Saccharomyces cerevisiae.

Gina Devasahayam, Daniel J Burke, Thomas W Sturgill

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Vesicular distribution of Secretory Pathway Ca²+-ATPase isoform 1 and a role in manganese detoxification in liver-derived polarized cells.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2011
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gina DevasahayamDepartment of Pharmacology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
Daniel J Burke
Thomas W Sturgill
University of Virginia · US

Funding

GENETIC CONTROL OF MITOTIC SPINDLE ASSEMBLY AND FUNCTIONR01GM040334 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BURKE, DANIEL J · 1993 to 2005
$1.4M
Regulation and Function of MAPKAP KinasesR01GM062890 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI STURGILL, THOMAS W · 2002 to 2005
$1.2M
GENETIC ANALYSIS OF REGULATED TUBULIN SYNTHESISR29GM040334 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BURKE, DANIEL J · 1988 to 1993
–
NIGMS NIH HHS GM40334NIGMS NIH HHS GM62890NIGMS NIH HHS R01 GM040334NIGMS NIH HHS R01 GM062890
6 · The paper itself

Abstract

The Pmr1 Golgi Ca2+/Mn2+ ATPase negatively regulates target of rapamycin complex (TORC1) signaling, the rapamycin-sensitive TOR complex in Saccharomyces cerevisiae. Since pmr1 causes resistance to rapamycin and tor1 causes hypersensitivity, we looked for genetic interactions of pmr1 with tor1. Deletion of TOR1 restored two wild-type phenotypes. Loss of TOR1 restored the ability of the pmr1 strain to grow on media containing 2 mm MnCl2 and conferred wild type as well as the wild-type sensitivity to rapamycin. Mn2+ additions to media partially suppressed rapamycin resistance of wild type and pmr1 tor1, suggesting that Tor1 and Tor2 are regulated by manganese. We parsed the roles of Ca2+ and Mn2+ transport and the compartments in rapamycin response using separation-of-function mutants available for Pmr1. A strain containing the D53A mutant (Mn2+ transporting) of Pmr1 is rapamycin sensitive, but the Q783A mutant (Ca2+ transporting) strain is rapamycin resistant. Mn2+ transport into the Golgi lumen appears to be required for rapamycin sensitivity. Overexpression of Ca2+ pump SERCA1, Ca2+/H+ antiporter Vcx1, or a Mn2+ transporting mutant of Vcx1 (Vcx1-M1) failed to restore rapamycin sensitivity, and loss of Pmr1 but not other transporters of Ca2+ or Mn2+ results in rapamycin resistance. Overexpression of Ccc1, a Fe2+ and Mn2+ transporter that has been localized to Golgi and the vacuole, does restore rapamycin sensitivity to pmr1Delta. We conclude that Mn2+ in the Golgi inhibits TORC1 signaling.

Indexed as

Biological TransportBlotting, WesternCalcium-Transporting ATPasesCation Transport ProteinsDrug ResistanceGolgi ApparatusImmunosuppressive AgentsManganeseMolecular ChaperonesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionSirolimusCalcium-Transporting ATPasesCation Transport ProteinsCCC1 protein, S cerevisiaeImmunosuppressive AgentsManganeseMolecular ChaperonesSaccharomyces cerevisiae ProteinsSirolimusSSC1 protein, S cerevisiae

Identifiers

PMID17603109
PMCPMC2013697
OpenAlexW2028846222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.